Related Experiment Video
Updated: Jun 26, 2026
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug
Zsuzsanna Schelz1, Hiba F Muddather1, Fatemeh Sheihaki Jaski1
1Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.
Abstract:
Cervical cancer presents a significant challenge to the global health of women. Despite substantial advances in human papillomavirus (HPV)-related cervical cancer vaccines, non-HPV-related cervical cancer is still waiting novel therapeutic options. Drug repurposing has provided a promising approach to improve cancer therapy in recent years. Our study aimed to explore the potential in vitro antineoplastic effects of levosimendan on cervical cancer cells. The antiproliferative effects of levosimendan were investigated on cervical cancer cells using a standard MTT assay. Fluorescent double staining was performed to identify its ability to induce apoptosis and necrosis. The possible mechanism of action of levosimendan was explored using cell-cycle analysis. Furthermore, antimetastatic effects were investigated using a wound-healing assay and a Boyden chamber assay. Our results revealed that levosimendan exhibited the highest growth-inhibitory effect in the HPV-negative C33A cell line. However, the effects were modest compared to the standard agent, cisplatin. Cell-cycle analysis detected that levosimendan can induce cell-cycle arrest in C33A cells by increasing the G1 and G2/M phases, decreasing the S phase, and enhancing the hypodiploid subG1 population. Levosimendan inhibited cell migration and invasion in a concentration-dependent manner. As levosimendan showed antimetastatic efficacy, it could be considered for repurposing to contribute to overcoming resistance to therapy in cervical cancer.
Insights
Levosimendan shows potential for repurposing in cervical cancer therapy. This drug demonstrated modest antiproliferative and antimetastatic effects in HPV-negative cervical cancer cells, warranting further investigation.
Area of Science:
- Oncology
- Pharmacology
Background:
- Cervical cancer remains a global health concern, particularly non-HPV-related types.
- Drug repurposing offers a promising avenue for novel cancer therapies.
Purpose of the Study:
- To investigate the in vitro antineoplastic effects of levosimendan on cervical cancer cells.
- To explore levosimendan's mechanism of action and antimetastatic potential.
Main Methods:
- Standard MTT assay for antiproliferative effects.
- Fluorescent double staining for apoptosis and necrosis.
- Cell-cycle analysis (G1, S, G2/M phases).
- Wound-healing and Boyden chamber assays for antimetastatic effects.
Main Results:
- Levosimendan exhibited modest growth inhibition in HPV-negative C33A cervical cancer cells.
- The drug induced cell-cycle arrest, increasing G1 and G2/M phases and decreasing the S phase.
- Levosimendan demonstrated concentration-dependent inhibition of cell migration and invasion.
- Apoptosis and necrosis were observed, with an enhanced hypodiploid subG1 population.
Conclusions:
- Levosimendan shows potential as an antimetastatic agent for cervical cancer.
- Drug repurposing of levosimendan may help overcome therapeutic resistance in cervical cancer.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers